China SXT Pharmaceuticals (SXTC) News Today → How to Make 100X on the AI Boom (From InvestorPlace) (Ad) Free SXTC Stock Alerts $1.04 -0.02 (-1.89%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 16, 2024 | msn.comJAGX, BSGM and SXTC among mid-day moversApril 16, 2024 | marketbeat.comTrading was temporarily halted for "SXTC" at 09:04 AM with a stated reason of "LULD pause."February 23, 2024 | wsj.comChina SXT Pharmaceuticals Inc.February 23, 2024 | benzinga.comChina SXT Pharmaceuticals Stock (NASDAQ:SXTC) Insider TradesFebruary 17, 2024 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. (SXTC)January 2, 2024 | markets.businessinsider.comDow Down 100 Points; US Manufacturing PMI Falls In DecemberDecember 31, 2023 | nasdaq.comChina SXT Pharma Continues To SpikeDecember 20, 2023 | morningstar.comChina SXT Pharmaceuticals Inc Ordinary Shares SXTCOctober 26, 2023 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price RuleOctober 26, 2023 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price RuleOctober 5, 2023 | marketbeat.comTrading was temporarily halted for "SXTC" at 09:10 AM with a stated reason of "LULD pause."October 4, 2023 | finanznachrichten.deChina SXT Pharmaceuticals, Inc.: China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitOctober 4, 2023 | markets.businessinsider.comChina SXT Pharma Ordinary Shares To Begin Trading On Split-Adjusted Basis On Oct. 5October 4, 2023 | finance.yahoo.comChina SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock SplitSeptember 7, 2023 | investorplace.comWhy Is China SXT Pharmaceuticals (SXTC) Stock Up 24% Today?August 25, 2023 | seekingalpha.comSXTC China SXT Pharmaceuticals, Inc.August 21, 2023 | markets.businessinsider.comWhy Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?August 2, 2023 | finance.yahoo.comChina SXT Pharmaceuticals Full Year 2023 Earnings: US$0.89 loss per share (vs US$5.52 loss in FY 2022)May 10, 2023 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price RuleMarch 29, 2023 | finance.yahoo.comInsiders who placed huge bets on China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) earlier this year would be disappointed with the 12% dropJanuary 10, 2023 | reuters.comChina says talks to include Paxlovid in its insurance drug list failJanuary 5, 2023 | benzinga.comChina SXT Pharmaceuticals Stock (NASDAQ:SXTC), Quotes and News SummaryMay 18, 2022 | seekingalpha.comChina SXT Pharmaceuticals announces 1-for-20 reverse stock splitMarch 29, 2022 | investorplace.comWhy Is China SXT Pharmaceuticals (SXTC) Stock Up Today?March 29, 2022 | seekingalpha.comChina SXT Pharmaceuticals climbs on heavy volumeMarch 15, 2022 | seekingalpha.comChina SXT Pharmaceuticals to raise $2.8M in convertible promissory note offeringMarch 14, 2022 | benzinga.comChina SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 MillionJanuary 20, 2022 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-AllotmentJanuary 20, 2022 | finance.yahoo.comAegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC).January 18, 2022 | finance.yahoo.comChina SXT Pharmaceuticals Shares Plunge On $3.5M Equity Raise Issued At Steep DiscountJanuary 18, 2022 | seekingalpha.comChina SXT Pharmaceuticals slumps on pricing $3.5M stock, pre-funded warrants offeringJanuary 18, 2022 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary SharesJanuary 14, 2022 | seekingalpha.comChina SXT Pharma announces proposed public offering of shares, prefunded warrantsJanuary 14, 2022 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary SharesJanuary 14, 2022 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Adds Newly Developed Kuihuapan and Zhudanfen Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of LuxuejinOctober 18, 2021 | finance.yahoo.comChina SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspection Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address America could fall from this event (Ad)America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash. Click here to see how you can protect yourself today. SXTC Media Mentions By Week SXTC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SXTC News Sentiment▼1.590.57▲Average Medical News Sentiment SXTC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SXTC Articles This Week▼30▲SXTC Articles Average Week Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aptevo Therapeutics News Aditxt News Comera Life Sciences News Histogen News Bellerophon Therapeutics News Athersys News Ampio Pharmaceuticals News Evofem Biosciences News SciSparc News Evelo Biosciences News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SXTC) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportGuard Against the Coming Financial UpheavalPorter & CompanyDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
